Insights about U.S. Stocks that landed in the Green-Zone during Thursday’s trade, are depicted underneath:

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s shares picked up 5.76%, and closed at $126.96. The stock has the beta value of 0.32, and its volatility for the week is 3.35%, while for the month it is 3.51%. The company has the market capitalization of $30.74B. The mean recommendation of analysts for this stock is 2.20. (where 1=Buy, 5=Sale).

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.

Arrowhead Research Corp (NASDAQ:ARWR), raised 5.73%, and closed at $7.94.

Arrowhead Research Corp. (ARWR), a biopharmaceutical corporation developing targeted RNAi therapeutics, declared the attainment of Novartis’ entire RNAi research and development portfolio and associated assets. The attainment comprises assignment of certain patents and patent applications owned or controlled by Novartis related to RNAi therapeutics, an exclusive license in the RNAi field to other patents and patent applications owned or controlled by Novartis, assignment of a third party license, three pre-clinical RNAi candidates, and other related assets. The corporation is hosting a conference call at 8:30 a.m. EST to talk about the attainment.

Key aspects of the attainment comprise the following:

• Multiple patent families covering RNAi-trigger design rules and modifications that fall outside of key patents controlled by competitors, which the Corporation believes provides freedom to operate for any target and indication;
• Novel intracellular targeting ligands that enhance the activity of RNAi-triggers by targeting the RNA-induced silencing complex (RISC) more effectively and improving stability once RISC is loaded;
• An assignment of Novartis’ license from Alnylam Pharmaceuticals granting Arrowhead access to Alnylam intellectual property, not including delivery, for 30 gene targets chosen by Novartis;
• A pipeline of three candidates initiated by Novartis and for which Novartis has developed varying amounts of preclinical data.

Arrowhead Research Corporation is a biopharmaceutical corporation developing targeted RNAi therapeutics. The corporation is leveraging its proprietary Dynamic Polyconjugate™ delivery platform to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead’s pipeline comprises ARC-520 for chronic hepatitis B virus, ARC-AAT for liver disease associated with Alpha-1 antitrypsin deficiency, and partner-based programs in obesity and oncology.

Navistar International Corp (NYSE:NAV) enhanced 5.46%, and closed at $30.30.

Navistar International Corporation (NAV) Release: International Truck recently declared a new body control module in conjunction with improved Diamond Logic® features. The new body control module, designed in line with Society of Automotive Engineer (SAE) 500k baud standards, will expand customer and truck equipment manufacturer electronics capabilities, driving more uptime. The new design will deliver six times the current processing speed for truck and body electronics, add sixteen more input/output slots for equipment manufacturers, and provide three additional data links to expand truck capabilities, and will be built in production starting in November 2015.

As a result of the new body control module design, new Diamond Logic features will be made accessible to raise uptime for customers. These new features comprise:

Intelligent Start – single ignition activation on the key is all that is required and the vehicle will manage starting the engine automatically. The starter motor is disabled the moment the engine starts, which prevents over cranking and overheating to extend starter life.

Programmable Real Time Starting – International® trucks can be programmed to start preceding to the driver’s arrival at specific time each day, ensuring the vehicle is warmed up and ready for operation. With real time starting, drivers can save time and effort, and fleets can raise productivity.

Auto Start-Stop – Auto Start-Stop not only reduces idle time and saves on fuel but allows vocational customers to recharge batteries automatically, or heat the cab for drivers without continuously running the engine.

Navistar International Corporation (NAV) is a holding corporation whose auxiliaries and associates produce International® brand commercial and military trucks, proprietary diesel engines, and IC Bus™ brand school and commercial buses. An associate also provides truck and diesel engine service parts.

Curis, Inc (NASDAQ:CRIS) enhanced 5.38%, and closed at $3.33.

Curis, Inc. (CRIS), a biotechnology corporation focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, declared that Dr. Mani Mohindru, Vice President, Corporate Strategy and Investor Relations, will present at the 27th Annual Roth Conference on Tuesday, March 10, 2015, at 12:00 p.m. Pacific Time in Dana Point, CA.

Curis is a biotechnology corporation focused on the development and commercialization of innovative drug candidates for the treatment of human cancers. Curis’ pipeline of drug candidates comprises CUDC-907, a dual HDAC and PI3K inhibitor, CUDC-427, a small molecule antagonist of IAP proteins, and CUDC-305, an oral HSP90 inhibitor.